Fundraising Fox

SmartPharm Therapeutics

Aspen, US · Founded 2017 · Delaware corporation

Healthtech

Founders & leadership

TB
Timothy BraunsExecutive
JT
Jose TrevejoExecutive
JT
John ThomasExecutive
JM
Jon MogfordExecutive
SG
Steve GorlinNamed on SEC filing

Board

MC
Michael CallahanBoard director

Reported raises · per SEC filings

Form D private placements

$10.5M disclosed across 1 round · 2018

▶$10.5MraisedApr 2019 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CallahanDirector
  • Timothy BraunsExecutive Officer
  • Jose TrevejoExecutive Officer, Director
  • John ThomasExecutive Officer
  • Jon MogfordExecutive Officer
  • Steve GorlinDirector
Offering amount
$10.5M
Amount sold
$10.5M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodiesfinance.yahoo.com · Nov 2020Is Sorrento Therapeutics a Good Coronavirus Stock to Buy? | Nasdaqnasdaq.com · Aug 2020

Frequently asked questions

How much funding has SmartPharm Therapeutics raised?
SmartPharm Therapeutics has disclosed $10.5M raised across 1 round.
Where is SmartPharm Therapeutics headquartered?
SmartPharm Therapeutics is headquartered in Aspen, US.